Topical treatment with 1% cyclosporine for subepithelial infiltrates secondary to adenoviral keratoconjunctivitis

Cornea

Volumn 29, Issue 6, 2010, Pages 638-640

  Levinger, Eliya ^a   Slomovic, Alana ^a   Sansanayudh, Wiwan ^a   Bahar, Irit ^a   Slomovic, Allan R ^a  

^a TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Cyclosporine 1 ; Subepithelial corneal infiltrates

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A;

ADENOVIRUS INFECTION; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FOREIGN BODY REACTION; GLARE; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; KERATOCONJUNCTIVITIS; MALE; MEDICAL RECORD REVIEW; PATIENT SATISFACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT; UNSPECIFIED SIDE EFFECT; VISUAL ACUITY;

ADENOVIRUS INFECTIONS, HUMAN; ADMINISTRATION, TOPICAL; CYCLOSPORINE; EPITHELIUM, CORNEAL; EYE INFECTIONS, VIRAL; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTRAOCULAR PRESSURE; KERATOCONJUNCTIVITIS; MALE; MIDDLE AGED; PROGNOSIS; QUESTIONNAIRES; RETROSPECTIVE STUDIES; VISUAL ACUITY;

EID: 77952950663     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e3181c33034     Document Type: Article

References (20)

1. Hillenkamp J, Reinhard T, Ross RS, et al. The effects of cidofovir 1% with and without cyclosporin a 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study. Ophthalmology. 2002;109:845-850. (Pubitemid 34465214)
2. Gordon YJMD, Araullo-Cruz TP, Romanowski EGMS. The effects of topical nonsteroidal anti-inflammatory drugs on adenoviral replication. Arch Ophthalmol. 1998;116:900-905.
3. Hillenkamp J, Reinhard T, Ross RS, et al. Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study. Arch Ophthalmol. 2001;119:1487-1491.
4. Lund OE, Stefani FH. Corneal histology after epidemic keratoconjunc-tivitis. Arch Ophthalmol. 1978;96:2085-2088.
5. Sahin A, Bozkurt B, Irkec M. Topical cyclosporine a in the treatment of superior limbic keratoconjunctivitis: a long-term follow-up. Cornea. 2008;27:193-195.
6. Ozcan AA, Ersoz TR, Dulger E. Management of severe allergic conjunctivitis with topical cyclosporin a 0.05% eyedrops. Cornea. 2007;26:1035-1038.
7. Doan S, Gabison E, Abitbol O, et al. [Efficacy of topical 2% cyclosporine A as a steroid-sparing agent in steroid-dependent vernal keratoconjunc-tivitis] . J Fr Ophtalmol. 2007;30:697-701.
8. Calne RY, Thiru S, McMaster P, et al. Cyclosporin A in patients receiving renal allografts from cadaver donors. J Am Soc Nephrol. 1998;9:1751-1756.
9. Nussenblatt RB, Palestine AG. Cyclosporine: immunology, pharmacology and therapeutic uses. Surv Ophthalmol. 1986;31:159-169.
10. Schweitzer C, Touboul D, Ghiringhelli C, et al. [A case report of a recurrence of Mooren's ulcer after cataract surgery]. J Fr Ophtalmol. 2007;30:e7.
11. Spadavecchia L, Fanelli P, Tesse R, et al. Efficacy of 1.25% and 1% topical cyclosporine in the treatment of severe vernal keratoconjunctivitis in childhood. Pediatr Allergy Immunol. 2006;17:527-532.
12. McCarthy JM, Dubord PJ, Chalmers A, et al. Cyclosporine A for the treatment of necrotizing scleritis and corneal melting in patients with rheumatoid arthritis. J Rheumatol. 1992;19:1358-1361.
13. Bonfioli AA, Damico FM, Curi AL, et al. Intermediate uveitis. Semin Ophthalmol. 2005;20:147-154.
14. Reinhard T, Sundmacher R. Topical cyclosporin A in Thygeson's superficial punctate keratitis. Graefes Arch Clin Exp Ophthalmol. 1999; 237:109-112.
15. Duszak RS. Diagnosis and management of Thygeson's superficial punctate keratitis. Optometry. 2007;78:333-338.
16. Sundmacher R, Hillenkamp J, Reinhard T. [Prospects for therapy and prevention of adenovirus keratoconjunctivitis]. Ophthalmologe. 2001;98: 991-1007; quiz 8-9.
17. Romanowski EG, Pless P, Yates KA, et al. Topical cyclosporine A inhibits subepithelial immune infiltrates but also promotes viral shedding in experimental adenovirus models. Cornea. 2005;24:86-91.
18. Kilic A, Gurler B. Topical 2% cyclosporine A in preservative-free artificial tears for the treatment of vernal keratoconjunctivitis. Can J Ophthalmol. 2006;41:693-698.
19. Reinhard T, Godehardt E, Pfahl HG, et al. [Local cyclosporin A in nummuli after keratoconjunctivitis epidemica. A pilot study]. Ophthalmologe. 2000;97:764-768.
20. Bohringer D, Wojanowski B, Reinhard T. Prolonged exposure to topical cyclosporine A does not seem to promote conjunctival malignancy. Acta Ophthalmol. 2008;86:462.